Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 clinical trial update evaluating Tarceva (erlotinib) in patients with locally advanced, metastatic, or recurrent non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy [Phase 2]
A Phase 2 trial evaluating individualized radiation dose escalation in Stage III non-small cell lung cancer using modern chemoradiotherapy w…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 study of ganetespib plus docetaxel in advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.
AstraZeneca-sponsored, multicenter retrospective chart review evaluating the potential clinical benefits of retreating EGFR-mutated non-smal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of radiation therapy with cisplatin and etoposide in unresectable non-small cell lung cancer; the s…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER) [Phase 2]
Phase 2 study of Tarceva (Erlotinib) in locally advanced or metastatic non-squamous non-small cell lung cancer completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
This update reports results from an observational study of Tarceva (erlotinib) in elderly patients with advanced non-small cell lung cancer;…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302） [Phase 2]
Phase II trial of Anlotinib in patients with advanced non-small cell lung cancer (ALTER0302) has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating gemcitabine with platinum-based chemotherapy, with or without cetuximab, as first-line treatment fo…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 1]
This is a Phase I trial assessing the safety and preliminary activity of combining cetuximab with gefitinib in patients with advanced or met…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
A SWOG-led clinical trial update on carcinogen exposure in lung tissue from smokers and non-smokers with newly diagnosed stage I-III non-sma…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized study comparing veliparib in combination with carboplatin and paclitaxel versus placebo in combination with carboplatin…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study evaluating the combination of dasatinib and erlotinib in non-small cell lung cancer. Resu…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/Phase 2 study of Tecemotide (L-BLP25) in participants with stage III unresectable …
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Computed Tomography (CT) Perfusion Imaging of Lung Cancer [NA]
A clinical trial evaluating CT perfusion imaging in non-small cell lung cancer was terminated; no results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors [Phase 1]
Phase Ib expansion study of intravenous CUDC-101 evaluating safety, efficacy, and pharmacokinetics in advanced head and neck, liver, breast,…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of combining pertuzumab with erlotinib in locally advanced or metastatic no…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients
Clinical trial update noting cognitive testing associated with prophylactic cranial irradiation in non-small cell lung cancer patients from …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC [Phase 2]
The document reports the completion of a Phase 2 clinical trial comparing BMS-690514 with erlotinib in patients with previously treated non-…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response [Phase 2]
Phase 2 trial of BMS-690514 in non-small cell lung cancer patients who are EGFR mutation positive or had prior response to gefitinib/erlotin…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer [Phase 2]
Phase II trial of a novel anti-angiogenic agent in combination with chemotherapy for non-small cell lung cancer; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types [Phase 2]
Phase II clinical trial of Brivanib (BMS-582664) across multiple tumor types has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with gemcitabine, with or without cisplatin, as first-line treatment in elderl…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib [Phase 1]
Phase 1 trial evaluating continuous once-daily oral afatinib (BIBW 2992) plus sirolimus (Rapamune) in patients with non-small cell lung canc…